Akso Health Group (NASDAQ:AHG) Stock Price Down 8.2% – Time to Sell?

Akso Health Group Sponsored ADR (NASDAQ:AHG) fell 8.2% on Thursday. The company traded as low as $1.30 and last traded at $1.2950. 679 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 80,391 shares. The stock had previously closed at $1.41.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Akso Health Group in a report on Thursday, October 15th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Akso Health Group currently has an average rating of “Sell”.

Akso Health Group Price Performance

The firm’s 50 day simple moving average is $1.01 and its two-hundred day simple moving average is $1.51.

Institutional Trading of Akso Health Group

A hedge fund recently bought a new stake in Akso Health Group stock. Citadel Advisors LLC purchased a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 46,026 shares of the company’s stock, valued at approximately $69,000. Institutional investors own 1.21% of the company’s stock.

Akso Health Group Company Profile

Akso Health Group Limited is a Cayman Islands holding company that operates through subsidiaries in China. The company is focused on the health and wellness sector, offering products and services intended to support consumers’ healthcare, nutrition and general well-being needs.

Akso Health Group’s activities include the distribution and sale of health-related products, including nutritional supplements and other wellness offerings, together with related health management and support services.